These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28327188)

  • 21. Allopurinol reduces the risk of myocardial infarction (MI) in the elderly: a study of Medicare claims.
    Singh JA; Yu S
    Arthritis Res Ther; 2016 Sep; 18(1):209. PubMed ID: 27655429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term allopurinol use decreases the risk of prostate cancer in patients with gout: a population-based study.
    Shih HJ; Kao MC; Tsai PS; Fan YC; Huang CJ
    Prostate Cancer Prostatic Dis; 2017 Sep; 20(3):328-333. PubMed ID: 28398294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly.
    Franchi C; Salerno F; Conca A; Djade CD; Tettamanti M; Pasina L; Corrao S; Marengoni A; Marcucci M; Mannucci PM; Nobili A;
    Eur J Intern Med; 2014 Nov; 25(9):847-52. PubMed ID: 25439099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency and risk factors of gout flares in a large population-based cohort of incident gout.
    Rothenbacher D; Primatesta P; Ferreira A; Cea-Soriano L; Rodríguez LA
    Rheumatology (Oxford); 2011 May; 50(5):973-81. PubMed ID: 21228059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative effectiveness of allopurinol versus febuxostat for preventing incident dementia in older adults: a propensity-matched analysis.
    Singh JA; Cleveland JD
    Arthritis Res Ther; 2018 Aug; 20(1):167. PubMed ID: 30075731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The risk of polymyalgia rheumatica in older adults with gout: a Medicare claims study.
    Singh JA; Cleveland JD
    Rheumatol Adv Pract; 2018; 2(2):rky024. PubMed ID: 31431970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
    Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR
    Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rates of adherence and persistence with allopurinol therapy among gout patients in Israel.
    Zandman-Goddard G; Amital H; Shamrayevsky N; Raz R; Shalev V; Chodick G
    Rheumatology (Oxford); 2013 Jun; 52(6):1126-31. PubMed ID: 23392592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort.
    Singh JA; Akhras KS; Shiozawa A
    Arthritis Res Ther; 2015 May; 17(1):120. PubMed ID: 25963969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medication adherence among gout patients initiated allopurinol: a retrospective cohort study in the Clinical Practice Research Datalink (CPRD).
    Scheepers LEJM; Burden AM; Arts ICW; Spaetgens B; Souverein P; de Vries F; Boonen A
    Rheumatology (Oxford); 2018 Sep; 57(9):1641-1650. PubMed ID: 29893941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence and persistence to urate-lowering therapies in the Irish setting.
    McGowan B; Bennett K; Silke C; Whelan B
    Clin Rheumatol; 2016 Mar; 35(3):715-21. PubMed ID: 25409858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The predictive value for major arrhythmic events of ventricular arrhythmias, particularly nonsustained ventricular tachycardias, in the subacute phase of a fibrinolyzed infarct. An analysis of GISSI-2 data. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Giani P; Avanzini F; Bagliani G; Galati A; Pucci P; Santoro E
    G Ital Cardiol; 1995 Jan; 25(1):77-87. PubMed ID: 7642014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allopurinol adherence and its predictors in gout: a national cohort study in US veterans.
    Singh JA; Richman J; Yang S; Bridges SL; Saag K
    Lancet Rheumatol; 2020 May; 2(5):e281-e291. PubMed ID: 33215163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with recurrent hospital admissions for gout: a case-control study.
    Hutton I; Gamble G; Gow P; Dalbeth N
    J Clin Rheumatol; 2009 Sep; 15(6):271-4. PubMed ID: 19734730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.
    Chohan S; Becker MA; MacDonald PA; Chefo S; Jackson RL
    Arthritis Care Res (Hoboken); 2012 Feb; 64(2):256-61. PubMed ID: 22052584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allopurinol Medication Adherence as a Mediator of Optimal Outcomes in Gout Management.
    Coburn BW; Bendlin KA; Sayles H; Meza J; Russell CL; Mikuls TR
    J Clin Rheumatol; 2017 Sep; 23(6):317-323. PubMed ID: 28816767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allopurinol adherence among patients with gout: an Italian general practice database study.
    Mantarro S; Capogrosso-Sansone A; Tuccori M; Blandizzi C; Montagnani S; Convertino I; Antonioli L; Fornai M; Cricelli I; Pecchioli S; Cricelli C; Lapi F
    Int J Clin Pract; 2015 Jul; 69(7):757-65. PubMed ID: 25683693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opportunities for improving medication use and monitoring in gout.
    Singh JA; Hodges JS; Asch SM
    Ann Rheum Dis; 2009 Aug; 68(8):1265-70. PubMed ID: 18701554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Achieving serum urate goal: a comparative effectiveness study between allopurinol and febuxostat.
    Hatoum H; Khanna D; Lin SJ; Akhras KS; Shiozawa A; Khanna P
    Postgrad Med; 2014 Mar; 126(2):65-75. PubMed ID: 24685969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allopurinol and the incidence of bladder cancer: a Taiwan national retrospective cohort study.
    Chen CJ; Hsieh MC; Liao WT; Chan YT; Chang SJ
    Eur J Cancer Prev; 2016 May; 25(3):216-23. PubMed ID: 25830898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.